Treatment of Periodontal Intrabony Defects With A-PRF or OFD
Efficacy of a New-generation Platelet-Rich Fibrin in the Treatment of Periodontal Intrabony Defects : a Randomized Clinical Trial
1 other identifier
interventional
30
1 country
1
Brief Summary
The aim of this randomized clinical trial was to clinically evaluate and compare the healing of intrabony defects after treatment with advanced platelet-rich fibrin (A-PRF+) toped flap debridement (OFD) in periodontitis patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2020
CompletedFirst Submitted
Initial submission to the registry
March 4, 2021
CompletedFirst Posted
Study publicly available on registry
April 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2024
CompletedApril 24, 2024
April 1, 2022
2.7 years
March 4, 2021
April 23, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Periodontal clinical parameters
to determine the clinical attachment level (CAL) With a calibrated periodontal probe we are examining the changes of periodontal probing depth (PPD) and gingival recession (GR) after surgical procedure in mm, the two parameters are used to determine the clinical attachment level (CAL).
Change from baseline after 6 month and after 12 month
Study Arms (2)
A-PRF Advanced Platelet-Rich Fibrin
ACTIVE COMPARATORComparing healing effect of an autologous product with open flap debridement.
OFD Open Flap Debridement
ACTIVE COMPARATORComparing healing effect of an autologous product with open flap debridement.
Interventions
Comparing healing effect of an autologous and open flap debridement
Eligibility Criteria
You may qualify if:
- no systemic diseases
- a good level of oral hygiene
- presence of a 2-, 3-, or combined 2-3-wall intrabony defect with a defect angle of 20-40 (+/- 5) degrees
- with a minimum PPD of 6 mm and intrabony component of a minimum 4 mm as detected on radiographs
- no smoking
You may not qualify if:
- systemic diseases that could influence the outcome of the therapy
- poor oral hygiene
- smoking
- horizontal bone loss
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Semmelweis University, Department of Periodontology
Budapest, 1088, Hungary
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dőri Ferenc, Professor
Semmelweis University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 4, 2021
First Posted
April 1, 2021
Study Start
February 1, 2020
Primary Completion
September 30, 2022
Study Completion
February 28, 2024
Last Updated
April 24, 2024
Record last verified: 2022-04